Inj vancomycin (hikma) 10mg
Products billed under this code include Vancomycin HCl.
Payment limit per 10 MG, by effective quarter, 1Q26 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Vancomycin HCl.
Payment limit per 10 MG, by effective quarter, 1Q26 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Vancomycin HCl | Hikma Pharmaceuticals USA Inc. | 00143-9161-10 | 500 | $8.00 |
| Vancomycin HCl | Hikma Pharmaceuticals USA Inc. | 00143-9161-25 | 1250 | $20.00 |
| Vancomycin HCl | Hikma Pharmaceuticals USA Inc. | 00143-9162-10 | 1000 | $16.00 |
| Vancomycin HCl | Hikma Pharmaceuticals USA Inc. | 00143-9163-01 | 500 | $8.00 |
| Vancomycin HCl | Hikma Pharmaceuticals USA Inc. | 00143-9164-01 | 1000 | $16.00 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $0.016 | −$0.001 | 10 MG | Inj vancomycin (hikma) 10mg | v1, posted September 17, 2026 |
| 3Q26 | $0.017 | +$0.003 | 10 MG | Inj vancomycin (hikma) 10mg | v1, posted September 15, 2026 |
| 2Q26 | $0.014 | −$0.005 | 10 MG | Inj vancomycin (hikma) 10mg | v1, posted September 15, 2026 |
| 1Q26 | $0.019 | – | 10 MG | Inj vancomycin (hikma) 10mg | v1, posted September 15, 2026 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.